Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-13-450003
Filing Date
2013-11-21
Accepted
2013-11-21 17:21:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 d633427d424b4.htm 424B4 24735
2 GRAPHIC g633425g42l43.jpg GRAPHIC 3413
3 GRAPHIC g633427g95w33.jpg GRAPHIC 24159
  Complete submission text file 0001193125-13-450003.txt   64199
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-187508 | Film No.: 131236090
SIC: 2835 In Vitro & In Vivo Diagnostic Substances